NCT00999752View on ClinicalTrials.gov

Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

May 31, 2010

Conditions
Hypertension
Interventions
DRUG

Nebivolol

5mg/day with increase to 10 mg/day to reach blood pressure \<140/90

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 25 mg/day

Trial Locations (1)

30084

Atlanta Vascular Research Foundation, Tucker

Sponsors
All Listed Sponsors
lead

InVasc Therapeutics, Inc.

INDUSTRY